急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03568 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、急性骨髄性白血病（AML）治療薬の世界市場について調査・分析し、急性骨髄性白血病（AML）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、幹細胞移植、標的療法、その他）、用途別（病院、ドラッグストア、外来診療センター、腫瘍学センター、診療所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の急性骨髄性白血病（AML）治療薬市場動向 ・主要企業別マーケットシェア ・急性骨髄性白血病（AML）治療薬の種類別市場規模2014-2019 （化学療法、放射線療法、幹細胞移植、標的療法、その他） ・急性骨髄性白血病（AML）治療薬の用途別市場規模2014-2019 （病院、ドラッグストア、外来診療センター、腫瘍学センター、診療所） ・急性骨髄性白血病（AML）治療薬の北米市場：主要企業・種類別/用途別市場規模 ・急性骨髄性白血病（AML）治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・急性骨髄性白血病（AML）治療薬の中国市場：主要企業・種類別/用途別市場規模 ・急性骨髄性白血病（AML）治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・急性骨髄性白血病（AML）治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・急性骨髄性白血病（AML）治療薬のインド市場：主要企業・種類別/用途別市場規模 ・急性骨髄性白血病（AML）治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb、Novartis、Roche、Genmab、GlaxoSmithKline Pharmaceuticals） ・急性骨髄性白血病（AML）治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

In 2018, the global Acute Myeloid Leukemia (AML) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Acute Myeloid Leukemia (AML) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Myeloid Leukemia (AML) Therapeutics development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb
Novartis
Roche
Genmab
GlaxoSmithKline Pharmaceuticals
…

Market segment by Type, the product can be split into
Chemotherapy
Radiation therapy
Stem Cell Transplant
Targeted Therapy
Others

Market segment by Application, split into
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Acute Myeloid Leukemia (AML) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Acute Myeloid Leukemia (AML) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Acute Myeloid Leukemia (AML) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiation therapy
1.4.4 Stem Cell Transplant
1.4.5 Targeted Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Retails Drug Stores
1.5.4 Ambulatory Care Centers
1.5.5 Oncology Centers
1.5.6 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Acute Myeloid Leukemia (AML) Therapeutics Market Size
2.2 Acute Myeloid Leukemia (AML) Therapeutics Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Acute Myeloid Leukemia (AML) Therapeutics Market Size by Manufacturers
3.1.1 Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Acute Myeloid Leukemia (AML) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players Head office and Area Served
3.3 Key Players Acute Myeloid Leukemia (AML) Therapeutics Product/Solution/Service
3.4 Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019)
4.2 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Acute Myeloid Leukemia (AML) Therapeutics Market Size (2014-2019)
5.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in United States
5.3 United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
5.4 United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application

6 Europe
6.1 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size (2014-2019)
6.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Europe
6.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
6.4 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application

7 China
7.1 China Acute Myeloid Leukemia (AML) Therapeutics Market Size (2014-2019)
7.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in China
7.3 China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
7.4 China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application

8 Japan
8.1 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size (2014-2019)
8.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Japan
8.3 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
8.4 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size (2014-2019)
9.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
9.4 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application

10 India
10.1 India Acute Myeloid Leukemia (AML) Therapeutics Market Size (2014-2019)
10.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in India
10.3 India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
10.4 India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size (2014-2019)
11.2 Acute Myeloid Leukemia (AML) Therapeutics Key Players in Central & South America
11.3 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type
11.4 Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.1.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.2.4 Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.3.4 Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Genmab
12.4.1 Genmab Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.4.4 Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
12.4.5 Genmab Recent Development
12.5 GlaxoSmithKline Pharmaceuticals
12.5.1 GlaxoSmithKline Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Myeloid Leukemia (AML) Therapeutics Introduction
12.5.4 GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
12.5.5 GlaxoSmithKline Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Acute Myeloid Leukemia (AML) Therapeutics Key Market Segments
Table Key Players Acute Myeloid Leukemia (AML) Therapeutics Covered
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation therapy Figures
Table Key Players of Radiation therapy
Figure Stem Cell Transplant Figures
Table Key Players of Stem Cell Transplant
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Others Figures
Table Key Players of Others
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Retails Drug Stores Case Studies
Figure Ambulatory Care Centers Case Studies
Figure Oncology Centers Case Studies
Figure Clinics Case Studies
Figure Acute Myeloid Leukemia (AML) Therapeutics Report Years Considered
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions 2014-2019
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions 2014-2019
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Manufacturers in 2018
Table Global Acute Myeloid Leukemia (AML) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Myeloid Leukemia (AML) Therapeutics Product/Solution/Service
Table Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Application in 2018
Figure United States Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2018-2019)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2014-2019)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2019)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2018-2019)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2014-2019)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2019)
Figure China Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2018-2019)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2014-2019)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2019)
Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2018-2019)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2014-2019)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2018-2019)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2019)
Figure India Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2018-2019)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2014-2019)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia (AML) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia (AML) Therapeutics Market Share (2018-2019)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2014-2019)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Details
Table Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Roche Company Details
Table Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Genmab Company Details
Table Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)(Million US$)
Figure Genmab Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
Table Genmab Recent Development
Table GlaxoSmithKline Pharmaceuticals Company Details
Table GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2014-2019)
Table GlaxoSmithKline Pharmaceuticals Recent Development
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Regions in 2025
Figure United States Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Acute Myeloid Leukemia (AML) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Product (2019-2025)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Product in 2025
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2019-2025)
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---